Precision medicine in Alzheimer's disease aims to personalize treatment based on an individual's genetic, biomarker, and lifestyle data. This approach acknowledges the heterogeneity of Alzheimer's, where symptoms and progression vary widely among patients. By analyzing genetic markers like APOE ε4 allele and biomarkers such as amyloid and tau proteins, clinicians can better predict disease risk, tailor interventions, and monitor treatment responses more effectively. Precision medicine also explores targeted therapies that address specific molecular pathways implicated in Alzheimer's pathology, potentially slowing or modifying disease progression. Integrating advanced technologies like genomics and neuroimaging enhances early detection and intervention strategies, offering hope for more personalized and effective care for individuals affected by Alzheimer's and related dementias.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China
Title : Neuroimaging-based evaluation of scalp acupuncture for neural repair and reorganization in children with cerebral palsy
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China
Title : Neurophysiological change and cognitive response to levetiracetam in Alzheimer disease: Testing the missing mechanistic link
Christopher Hubler, Emergent Neural Systems Institute for Research, United States
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia